Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in Korea

Inclusion Criteria General Inclusion Criteria: All patients approved for HM3 implantation in Korea as per HIRA guidelines will be eligible to be enrolled in the PMS. Only the patients who provide written informed consent will be included in the study. If a subject has had an outcome after the HM3 implantation but prior to providing informed consent, no consent will be obtained, and a limited anonymized data will be collected. Exclusion Criteria General Exclusion Criteria: This post market surveillance does not have specific exclusion criteria